Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2002
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465507 Antitumor agents
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
10/15/2002US6465441 Screening method for modulation of human mast cell activation
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002US6464959 Protective colloid stabilizer.
10/15/2002US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/15/2002CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079221A2 Sapogenin derivatives, their synthesis and use
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079168A1 Imidazolyl derivatives useful as histamine h3 receptor ligands
10/10/2002WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078747A2 Pregabalin lactose conjugates
10/10/2002WO2002078741A2 Methods and compositions for modulating the immune system of animals
10/10/2002WO2002078723A1 A pharmaceutical preparation for asthma
10/10/2002WO2002078707A1 Pyrrolidine sulfonamides
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002WO2002078618A2 Methods of modulating surfactant production
10/10/2002WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002010343A3 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001093845A3 Carboxyalkylether-acat inhibitor combinations
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147346 New crystal modification of torasemide
10/10/2002US20020147344 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
10/10/2002US20020147343 Cell antiproliferative agents; anticancer agents
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147222 Brain disorders; Alzheimer's disease
10/10/2002US20020147220 Norcisapride; sleep disorders, eating disorders, irratible bowel disorders
10/10/2002US20020147216 Mucin synthesis inhibitors
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147189 Immunology response; autoimmune disease
10/10/2002US20020147138 Anticancer agents
10/10/2002US20020146463 Useful as food additives or in medicaments
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442150A1 Sapogenin derivatives, their synthesis and use, and methods based upon their use
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2437095A1 Methods and compositions for modulating the immune system of animals
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246810A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 878